Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma

Clinical trial NCT01080391 · COMPLETED

Trial details

NCT number: NCT01080391
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Relapsed Multiple Myeloma

Start date: 2010-07-14
Primary completion: 2014-06-16
Enrollment: 792

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.